Profarma Distribuidora de Produtos Farmacêuticos S.A. Stock
Stocks
PFRM3
BRPFRMACNOR1
Pharmaceuticals
|
Market Closed -
Sao Paulo
04:04:00 2026-09-24 pm EDT
|
5-day change | 1st Jan Change | ||
| 7.130 BRL | +0.71% |
|
-6.55% | -21.91% |
| Market Cap | 874M 168M 148M 140M 127M 238M 16.17B 240M 1.68B 649M 8.23B 632M 619M 26.77B | P/E 2024 |
6.95x | P/E 2025 | 9.42x |
|---|---|---|---|---|---|
| Enterprise Value | 2.04B 393M 346M 326M 297M 556M 37.74B 561M 3.91B 1.52B 19.21B 1.48B 1.44B 62.5B | EV / Sales 2024 |
0.18x | EV / Sales 2025 | 0.2x |
| Free-Float |
32.86% | Yield 2024 |
8.86% | Yield 2025 | - |
| 1 day | +0.71% | ||
| 1 week | -6.55% | ||
| Current month | -4.30% | ||
| 1 month | -3.12% | ||
| 3 months | +11.06% | ||
| 6 months | -3.78% | ||
| Current year | -21.91% |
| 1 week | 7.04 |  | 7.77 |
| 1 month | 7.04 | | 7.97 |
| Current year | 6.11 | | 9.7 |
| 1 year | 6.11 | | 9.7 |
| 3 years | 3.4 | | 9.7 |
| 5 years | 2.92 | | 9.7 |
| 10 years | 2.87 | | 11.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CEO | Chief Executive Officer | 58 | 2010-04-20 |
| Director of Finance/CFO | 68 | 1992-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sammy Birmarcker
CHM | Chairman | 58 | 2008-04-02 |
| Director/Board Member | 91 | 2010-04-20 | |
| Director/Board Member | 62 | 2010-04-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/25 | Others | 1 | 0.0000% | - | ||
| 12/9/24 | Sell | 12,200 | 0.0099% | |||
| 12/9/24 | Sell | 12,400 | 0.0100% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | -6.55% | -5.44% | +84.72% | 176M | |
| -1.27% | -1.16% | +14.30% | +98.19% | 103B | |
| +0.61% | -1.64% | +44.02% | +150.25% | 51.24B | |
| -0.78% | +0.39% | -14.67% | +265.71% | 20.74B | |
| -0.25% | -0.87% | -11.20% | -10.55% | 7.96B | |
| -1.66% | -0.34% | -38.67% | -34.93% | 6.92B | |
| -0.68% | +2.35% | -4.34% | +15.63% | 6.59B | |
| -1.61% | -2.26% | -20.09% | -34.02% | 5.99B | |
| +0.12% | -0.72% | -2.66% | +18.76% | 4.96B | |
| +1.02% | +8.52% | +20.18% | +22.51% | 3.76B | |
| Average | -0.37% | +0.20% | -1.86% | +57.63% | 21.1B | |
| Weighted average by Cap. | -0.65% | -0.69% | +14.10% | +109.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 10.15B 1.96B 1.72B 1.62B 1.48B 2.77B 188B 2.79B 19.46B 7.54B 95.56B 7.34B 7.18B 311B | 11.45B 2.21B 1.94B 1.83B 1.67B 3.12B 212B 3.15B 21.95B 8.51B 108B 8.28B 8.1B 351B |
| Net income | 115M 22.07M 19.42M 18.3M 16.7M 31.23M 2.12B 31.47M 220M 85.11M 1.08B 82.88M 81.08M 3.51B | 119M 22.91M 20.15M 18.99M 17.33M 32.41M 2.2B 32.66M 228M 88.32M 1.12B 86M 84.13M 3.64B |
| Net Debt | 1.02B 196M 172M 162M 148M 277M 18.81B 279M 1.95B 756M 9.57B 736M 720M 31.15B | 1.17B 225M 198M 186M 170M 318M 21.57B 320M 2.24B 867M 10.98B 844M 826M 35.73B |
Employees
7,077
Sector
Pharmaceuticals
Calendar
Oct. 27
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | R$7.130 | -3.65% | 158,700 |
| 26-09-23 | R$7.400 | -2.76% | 135,400 |
| 26-09-22 | R$7.610 | -1.55% | 74,500 |
| 26-09-21 | R$7.730 | +1.31% | 55,600 |
| 26-09-18 | R$7.630 | 0.00% | 109,000 |
- Stock Market
- Stocks
- PFRM3 Stock
Select your edition
All financial news and data tailored to specific country editions
